MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN

Volume: 111, Pages: 1103 - 1111
Published: Mar 1, 2019
Abstract
Lung cancer is the leading cause in all cancer deaths. A low survival rate and high recurrence rate of lung cancer make the endeavor to identify new, more effective therapies a primary goal. MicroRNAs (miRNAs) are regarded as regulators of tumorigenesis and it is known that miR-183-5p is significantly upregulated in non-small cell lung cancer (NSCLC), suggesting it has an oncogenic function in lung cancer. In this study, we found that miR-183-5p...
Paper Details
Title
MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN
Published Date
Mar 1, 2019
Volume
111
Pages
1103 - 1111
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.